Does MTHFR Cause Depression, Anxiety, or ADD?
Reader takeaway: A variant in the MTHFR gene is linked in some research to depression, ADD, and anxiety but is not the sole cause of these disorders. More important and useful may be actual nutritional deficiencies such as folate, B12 or riboflavin. |
If you have ever searched for the reasons behind anxiety, low mood, poor focus, or emotional overload, you may have encountered a remarkably tidy explanation: it is your MTHFR variant. This idea is so appealing in its simplicity. Methylenetetrahydrofolate reductase (MTHFR) participates in folate metabolism, and folate metabolism supports methylation and other reactions needed by the brain to build neurotransmitters. It is easy to imagine that a less efficient version of this enzyme could explain how you feel.
The biology is real, but the conclusion is, sadly, oversimplified. Common MTHFR variants may make a contribution to mental health susceptibility but by themselves they cannot diagnose anxiety, attention-deficit/hyperactivity disorder (ADHD), or depression, predict your symptoms, or tell you which supplement you need. Sorry.
What MTHFR Does in the Brain
The MTHFR enzyme helps convert folate into 5-methyltetrahydrofolate, commonly called 5-MTHF or methylfolate. This form of folate helps convert homocysteine to methionine. Methionine can then be used to make S-adenosylmethionine (SAMe), the molecule that supplies methyl groups for most reactions in the body.
These reactions help regulate gene activity, maintain cell membranes, and support normal nervous-system function. Folate metabolism also intersects with pathways involved in producing and regulating neurotransmitters. Vitamin B12, vitamin B6, riboflavin, choline, betaine, protein intake, kidney function, medications, and overall nutritional status can all influence the larger system (1).
This means MTHFR is relevant to and can affect brain biology. It does not mean a common MTHFR variant is the only cause for something as complex as anxiety, depression, or ADD.
Does MTHFR Cause Depression, Anxiety, or ADD? What Depression Research Shows
The MTHFR C677T variant, identified as rs1801133, is the most studied MTHFR variant in psychiatric research. People inherit two copies of the gene, so their genotype may be CC (wild type or normal), CT (heterozygous or one variant copy), or TT (homozygous or two variant copies). The TT genotype generally results in low MTHFR enzyme activity, especially when folate or riboflavin status is inadequate.
A meta-analysis of 26 studies involving 4,992 people with depression and 17,082 controls found a modest association between C677T and depression. The association was stronger in Asian populations and small or marginal in several other groups. That is a population-level difference, not a prediction about an individual (2). So having this variant may make it slightly more likely that a person experiences depression, but doesn't mean that MTHFR causes it or that everyone with this genetic variation will have it.
Genetic association studies are also vulnerable to differences in ancestry, folate fortification, diet, diagnostic methods, and publication bias. Even when an association is statistically significant, the variant explains only a tiny portion of why depression develops.
Depression is influenced by many genes alongside sleep, chronic stress, trauma, illness, hormones, medication effects, substance use, social conditions, and other factors. An MTHFR result cannot tell you whether you have depression or why it developed.
The Evidence Is Thinner for ADHD and Anxiety
The ADHD evidence is substantially more limited. A 2022 meta-analysis found an association between MTHFR A1298C and ADHD, but its ADHD analysis included only five studies with 434 cases and 670 controls (3).
ADHD is a complex neurodevelopmental condition involving many genetic and environmental influences. Focus problems can also arise from sleep disorders, anxiety, depression, medication effects, thyroid disorders, iron deficiency, and other health concerns. A genetic report cannot distinguish among these possibilities.
For anxiety, the case is weaker still. Research has examined MTHFR in individual anxiety-related conditions and populations, but there is no consistent body of evidence showing that a common MTHFR variant explains anxiety in an individual. Symptoms such as racing thoughts, panic, insomnia, irritability, and physical tension should not be used to infer someone’s MTHFR status.
Nutrient Status May Matter More Than a Single Variant
Low folate or vitamin B12 status can affect the nervous system, and observational studies have found associations between low levels and depression. In older adults, one meta-analysis found associations between depression and both low folate and low B12. However, observational associations cannot establish whether the nutrient deficiency caused depression. Depression itself may affect appetite, diet quality, alcohol intake, medication use, and self-care so this may be a self-perpetuationg cycle or depression may be responsible for the nutritional deficiencies (4).
Trials of folate and B12 have also produced mixed results. A systematic review found that short-term supplementation did not meaningfully reduce depressive symptoms in adults already receiving antidepressants. Longer-term benefits were possible in certain populations, but the number of trials was small and their methods varied considerably (5).
Deficiencies do deserves attention and are important in your own health. Correcting a documented folate or B12 deficiency boosts your body's strength and ability to cope with other stressors and is important for good self-care and ongoing health.
Depending on a person’s history and symptoms, a clinician might consider a blood count, serum B12, methylmalonic acid, folate, homocysteine, iron studies, or thyroid testing. Homocysteine is not a stand-alone “methylation score,” although it is the most accurate marker we have currently. It can be affected by several nutrients, kidney function, age, smoking, medications, and health conditions.
Where L-Methylfolate Fits
L-methylfolate has been studied as an adjunctive treatment for adults with major depressive disorder who did not respond adequately to an antidepressant. A systematic review and meta-analysis found a modest improvement when L-methylfolate was added to antidepressant treatment, although the evidence base was relatively small (6). One trial using lower and then higher amounts did not find a significant benefit. A second trial using 15 mg daily found that L-methylfolate performed better than placebo when added to a selective serotonin reuptake inhibitor (7).
That 15 mg amount is far above the nutrient quantities found in ordinary foods and many multivitamins. It was studied as a clinician-supervised psychiatric intervention, not as a general recommendation for everyone with an MTHFR variant. The evidence does not show that an MTHFR result alone identifies who will respond. High-dose methylfolate can also complicate an undiagnosed vitamin B12 deficiency and may not be appropriate for everyone. People with bipolar disorder or a history of hypomania or mania should be particularly cautious about products intended to influence mood.
A Useful Way to Respond to Your MTHFR Result
If you have an MTHFR result and mental health symptoms, start with the symptoms rather than building a treatment plan around the SNP. Seek an appropriate evaluation for persistent anxiety, depression, sleep disruption, or attention problems. Review your diet, medications, alcohol intake, sleep, menstrual or hormonal changes, health conditions, and current supplements. If deficiency is plausible, simple blood tests may be the best first step. While blood tests for folate are notoriously unreliable, your doctor can still help you find a path forward.
Food remains a sensible way to support one-carbon metabolism, or methylation. Folate-rich choices include lentils, beans, leafy vegetables, asparagus, avocado, and citrus fruit. Eggs, dairy foods, fish, and meat can provide vitamin B12 or choline, depending on the food. People eating little or no animal-derived food need a reliable source of B12, but the appropriate product and amount depend on individual circumstances.
Do not start or stop psychiatric medication based on an MTHFR report. New suicidal thoughts, an inability to stay safe, hallucinations, severe agitation, or possible mania require prompt professional help. In an emergency, contact local emergency services or an appropriate crisis service. Your MTHFR variant is one small piece of your biology. It is not a verdict on your mood, attention, resilience, or future. Mental health conditions are complex, and useful care usually comes from looking at the whole person rather than asking one common genetic variant to explain everything.
References
Friso S, Udali S, De Santis D, Choi SW. One-carbon metabolism and epigenetics. Molecular Aspects of Medicine. 2017;54:28-36. doi:10.1016/j.mam.2016.11.007. PMID: 27876555.
Wu YL, Ding XX, Sun YH, et al. Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013;46:78-85. doi:10.1016/j.pnpbp.2013.06.015. PMID: 23831680.
Meng X, Zheng JL, Sun ML, et al. Association between MTHFR (677C>T and 1298A>C) polymorphisms and psychiatric disorder: A meta-analysis. PLOS ONE. 2022;17(7):e0271170. doi:10.1371/journal.pone.0271170. PMID: 35834596.
Petridou ET, Kousoulis AA, Michelakos T, et al. Folate and B12 serum levels in association with depression in the aged: A systematic review and meta-analysis. Aging & Mental Health. 2016;20(9):965-973. doi:10.1080/13607863.2015.1049115. PMID: 26055921.
Almeida OP, Ford AH, Flicker L. Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression. International Psychogeriatrics. 2015;27(5):727-737. doi:10.1017/S1041610215000046. PMID: 25644193.
Al Maruf A, Poweleit EA, Brown LC, et al. Systematic review and meta-analysis of L-methylfolate augmentation in depressive disorders. Pharmacopsychiatry. 2022;55(3):139-147. doi:10.1055/a-1681-2047. PMID: 34794190.
Papakostas GI, Shelton RC, Zajecka JM, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind, parallel-sequential trials. American Journal of Psychiatry. 2012;169(12):1267-1274. doi:10.1176/appi.ajp.2012.11071114. PMID: 23212058.
Comments